Adverse Outcome Pathway Development II: Best Practices
Daniel L. Villeneuve(Environmental Protection Agency), Maurice Whelan(University of Minnesota), Lucia Vergauwen(University of Antwerp), Doug Crump(Environment and Climate Change Canada), Carlie A. LaLone(Environmental Protection Agency), Brigitte Landesmann(University of Minnesota), Natàlia García‐Reyero(Biocom), Markus Hecker(University of Saskatchewan), Teresa Lettieri(European Commission), Sharon Munn(University of Minnesota), Nepelska Malgorzata(University of Minnesota), Thomas H. Hutchinson(University of Plymouth), Mary Ann Ottinger(University of Houston)
Cited by 261
Related Papers
Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment
|Environmental Toxicology and Chemistry|2009|2.6k
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose–response framework
|Toxicology and Applied Pharmacology|2007|755
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725
Aging in Rhesus Monkeys: Relevance to Human Health Interventions
|Science|2004|363
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
|Journal of Alzheimer s Disease|2010|325